Patent-family-88839089
Applicants:
- University of Copenhagen [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD]
- UNIV COPENHAGEN [NORA names: KU University of Copenhagen; University]
- EG 427
Abstract
The present invention provides a method for treating spasticity in a subject. The method includes direct administration of a herpes simplex virus 1 (HSV-1) vector harboring a glutamic acid decarboxylase (GAD) gene (preferably, GAD67) into one or more dermatomes of the subject.
Patent Family Records (1)
VIRAL VECTOR ENCODING GAD FOR TREATING SPASTICITY
EG 427, UNIV COPENHAGEN, University of Copenhagen SAREK GRZEGORZ F, FINK DAVID J, Bellardita, Carmelo-
2024, WO-2024120772-A1